Autologous bone marrow transplantation following high dose chemotherapy for the treatment of adult patients with acute myeloid leukaemia
- 1 November 1986
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 64 (3) , 529-537
- https://doi.org/10.1111/j.1365-2141.1986.tb02209.x
Abstract
Adult patients [24] with acute myeloid leukaemia (AML) were treated with intensive chemotherapy followed by autologous marrow rescue. The procedure was repeated twice in eight patients. Eleven of 16 patients treated in first remission continue in first unmaintained remission (9-54 months, median 17 months). Eight patients treated at relapse or second remission have relapsed again and died within 14 months of their first autologous bone marrow transplant (ABMT). This form of intensification therapy would appear valuable for adult AML patients in first remission.This publication has 10 references indexed in Scilit:
- Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromesBlood, 1985
- ISOLATED THROMBOCYTOPENIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - EXISTENCE OF TRANSIENT AND CHRONIC THROMBOCYTOPENIC SYNDROMES1985
- TRANSPLANTATION OF UNPURGED AUTOLOGOUS BONE-MARROW IN ACUTE MYELOID LEUKAEMIA IN FIRST REMISSIONThe Lancet, 1984
- Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemiaThe American Journal of Medicine, 1984
- Platelet‐ and Granulocyte‐Specific Antibodies after Allogeneic and Autologous Bone Marrow Grafts1Vox Sanguinis, 1984
- Chemotherapy for acute myelogenous leukemia in children and adults: VAPA updateBlood, 1983
- Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cellsBlood, 1983
- TRANSPLANTATION FOR SEVERE COMBINED IMMUNODEFICIENCY WITH HLA-A,B,D,DR INCOMPATIBLE PARENTAL MARROW-CELLS FRACTIONATED BY SOYBEAN AGGLUTININ AND SHEEP RED-BLOOD-CELLS1983
- USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982
- Bone marrow processing and cryopreservation.Journal of Clinical Pathology, 1982